![The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial - The](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2f9746ff-a56a-4d1f-9fa7-5e6b9f11a6ee/gr1_lrg.jpg "The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial - The")
The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial - The
Mayo Clinic Rochester Publishes Updated Multiple Myeloma Survival Rates! - Multiple Myeloma - Survival Rate Statistics by Hospital
Real-World Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Relapsed or Refractory Multiple Myeloma: Evidence from a Medical Record Review in France
A Multiple Myeloma Roundtable: Treatment Trends and Recent Clinical Advances
Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry | Haematologica
Figure 1 from Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. | Semantic Scholar
Frontiers | Staging System to Predict the Risk of Relapse in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
Progression-free and overall survival for high-risk patients with relapsed or refractory multiple myeloma (RRMM) who received carfilzomib-based regimens
Retrospective analysis of 264 multiple myeloma patients
Overall survival of 3664 patients with multiple myeloma, according to... | Download Scientific Diagram
Outcome and survival of myeloma patients diagnosed 2008–2015. Real-world data on 4904 patients from the Swedish Myeloma Registry | Haematologica
Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma - ScienceDirect
Daratumumab, Lenalinomide, and Dexamethasone for Myeloma | NEJM Resident 360
Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population - Clinical Lymphoma, Myeloma and Leukemia
Trends in the multiple myeloma treatment landscape and survival: a U.S. analysis using 2011–2019 oncology clinic electronic he
Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients | PLOS ONE
Myeloma survival statistics | Cancer Research UK
Blog Archives - Multiple Myeloma - Survival Rate Statistics by Hospital
Overall survival from diagnosis of multiple myeloma, according to world... | Download Scientific Diagram
Improved long-term survival in multiple myeloma up to the age of 80 years | Leukemia
Kaplan-Meier curves for overall survival for patients with genetic... | Download Scientific Diagram
Overall survival (OS) in 253 patients with multiple myeloma... | Download Scientific Diagram
Survival Of Multiple Myeloma Patients Significantly Increases Over Last Decade
The Clinical Course of Multiple Myeloma in the Era of Novel Agents: A Retrospective, Single-Center, Real-World Study | Atlantis Press
Duration of Survival in Patients with Myeloma Treated with Thalidomide | NEJM
